• Welcome to the Center for Molecular Imaging.
    Welcome to the Center for Molecular Imaging.
    The major focus of the CMI is the development of imaging technology and contrast agents to see human disease at its earliest possible manifestation.
  • We believe that Seeing is Curing.™
    We believe that Seeing is Curing.™
    If a disease can be seen, it can be diagnosed and treated—and there is a greater likelihood of finding a cure.
  • Our focus is Bench-to-Bedside medicine.
    Our focus is Bench-to-Bedside medicine.
    Scientific theory needs to move from the laboratory bench to the patient’s beside to be beneficial—our focus is on development of practical clinical solutions.
  • Collaboration brings us closer to the cure.
    Collaboration brings us closer to the cure.
    Working with a team of local, national, and international collaborators, we freely share ideas and data to move closer to a cure for human diseases.
  • The future is Personalized Medicine.
    The future is Personalized Medicine.
    We are developing the next generation of imaging technology to permit medical decisions based on the individual needs of the patient.

Our Mission

Our mission is to solve important clinical problems by applying first principles from chemistry and engineering.

We believe that Seeing is Curing - that is, if we can see cancer at an earlier stage than we now can (currently about 1 billion cells) we will have a greater likelihood of curing it.

Molecular Images

Seeing is Curing

A. LAM tumor in the lung with hematoxylin and
    eosin (H&E) staining
B. PET/CT using F-18-FDG
C. Thyroid uptake of pertechnetate by SPECT/CT
D. Prostate cancer with H&E staining

  • Featured News
  • 12/21/2011

    Choi Laboratory Opens in New Location: Dr. Hak Soo Choi and his research team have expanded to a full-capabilities lab in molecular biology, chemistry, and physiology in the Dana-Slosberg research building.  Dr. Choi commented, "We are so excited about the new lab because we have room to develop contrast agents more efficiently - from in silico design to in vitro cell screening as well as in vivo animal testing - all in one place."

  • 5/24/2011

    Frangioni Lab Receives Morrison Day Awards: Nicholas Durr, Ph.D. wins Best Poster Award, and Sylvain Gioux, Ph.D. and Yang Xie, B.A. win the Best Scientific Presentation Awards at the 16th annual Morrison Research Day hosted by Dr. Robert Lenkinski and the Department of Radiology.

    The Morrison Research Day honors Lawrie B. Morrison, M.D., who established radiology departments at New England Deaconess, Baptist, Faulkner, Cory Hill, and Robert Breck Brigham Hospitals. A pioneer in the field, Dr. Morrison helped define the role of radiology in the diagnosis of hip and colon cancer.

  • 4/19/2011

    Dr. John Frangioni Promoted: We are very proud to announce the academic promotion of John Frangioni, M.D., Ph.D., to Professor of Medicine at Harvard Medical School.

    Dr. Frangioni is also an Associate Professor of Radiology at Harvard Medical School. He is board certified in internal medicine and medical oncology, and is an Attending Physician in the Division of Hematology/Oncology at the Beth Israel Deaconess Medical Center.